Cargando…

Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN)

BACKGROUND: Most of the studies on cystic fibrosis (CF) focused on SARS-CoV-2 prevalence and suggested a low incidence of infection in this population. We aimed to assess the impact of the pandemic and related lockdown measures implemented in May 2020 in response to the first wave of SARS-CoV-2 infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Oubaya, Nadia, Pombet, Thibaud, Delestrain, Celine, Remus, Natascha, Douvry, Benoit, Grenet, Dominique, Corvol, Harriet, Thouvenin, Guillaume, Prulière-Escabasse, Virginie, Mounir, Hakima, Argoud, Dominique, Fretigne, Cédric, Costes, Laurence, Mackiewicz, Marie-Pierre, Jung, Camille, Ahamada, Laitissia, Lanone, Sophie, Maitre, Bernard, Bégot, Anne-Cécile, Epaud, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703073/
https://www.ncbi.nlm.nih.gov/pubmed/36452951
http://dx.doi.org/10.3389/fpubh.2022.978627
_version_ 1784839782826770432
author Oubaya, Nadia
Pombet, Thibaud
Delestrain, Celine
Remus, Natascha
Douvry, Benoit
Grenet, Dominique
Corvol, Harriet
Thouvenin, Guillaume
Prulière-Escabasse, Virginie
Mounir, Hakima
Argoud, Dominique
Fretigne, Cédric
Costes, Laurence
Mackiewicz, Marie-Pierre
Jung, Camille
Ahamada, Laitissia
Lanone, Sophie
Maitre, Bernard
Bégot, Anne-Cécile
Epaud, Ralph
author_facet Oubaya, Nadia
Pombet, Thibaud
Delestrain, Celine
Remus, Natascha
Douvry, Benoit
Grenet, Dominique
Corvol, Harriet
Thouvenin, Guillaume
Prulière-Escabasse, Virginie
Mounir, Hakima
Argoud, Dominique
Fretigne, Cédric
Costes, Laurence
Mackiewicz, Marie-Pierre
Jung, Camille
Ahamada, Laitissia
Lanone, Sophie
Maitre, Bernard
Bégot, Anne-Cécile
Epaud, Ralph
author_sort Oubaya, Nadia
collection PubMed
description BACKGROUND: Most of the studies on cystic fibrosis (CF) focused on SARS-CoV-2 prevalence and suggested a low incidence of infection in this population. We aimed to assess the impact of the pandemic and related lockdown measures implemented in May 2020 in response to the first wave of SARS-CoV-2 infection on healthcare access, health, and behavior in CF patients. METHODS: A national questionnaire opened online from May 15th, 2020 to June 11(th), 2020 was completed by 751 CF-patients, aged 14 years and over. It comprised questions about access to healthcare, anxiety and depression, smoking, alcohol, drug and psychotropic drug consumption, adherence to CF treatment, and constraints. A semi-structured comprehensive interview was performed no later than 1 month after the end of the lockdown in 16 CF-patients. RESULTS: The mean age of the population was 28.0 [interquartile range (IQR) 20.0–37.0] years old. More than 75% of in-person consultations scheduled during the lockdown were canceled. Alternatively, 27% were postponed, and telehealth consultations were proposed and accepted in almost 40% of cases. More than 75% of the scheduled physiotherapy sessions were canceled and replaced mainly by self-drainage. Annual follow-up clinic visits were consistently postponed whereas required hospitalizations at CF centers for exacerbation were maintained in most cases. While 43.2% CF-patients had signs of anxiety, 51.0% presented symptoms of depression, both associated with increased use of psychotic medications and inversely correlated to COVID-19 prevalence. Among the lower and lower middle classes, very little medical information was obtained or requested by the patient, participation to sports or other activities was low, while excessive home confinement and isolation were more frequent. In contrast, in the upper middle and upper classes, individuals solicitated help to their CF centre, had more physical activities, and maintained contact with friends or families. CONCLUSION: The first lockdown in France had only minimal impact on the management care of CF-patients but was associated with increased symptoms of anxiety and depression, together with behavioral changes that varied with social class. TRIAL REGISTRATION: NCT04463628.
format Online
Article
Text
id pubmed-9703073
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97030732022-11-29 Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN) Oubaya, Nadia Pombet, Thibaud Delestrain, Celine Remus, Natascha Douvry, Benoit Grenet, Dominique Corvol, Harriet Thouvenin, Guillaume Prulière-Escabasse, Virginie Mounir, Hakima Argoud, Dominique Fretigne, Cédric Costes, Laurence Mackiewicz, Marie-Pierre Jung, Camille Ahamada, Laitissia Lanone, Sophie Maitre, Bernard Bégot, Anne-Cécile Epaud, Ralph Front Public Health Public Health BACKGROUND: Most of the studies on cystic fibrosis (CF) focused on SARS-CoV-2 prevalence and suggested a low incidence of infection in this population. We aimed to assess the impact of the pandemic and related lockdown measures implemented in May 2020 in response to the first wave of SARS-CoV-2 infection on healthcare access, health, and behavior in CF patients. METHODS: A national questionnaire opened online from May 15th, 2020 to June 11(th), 2020 was completed by 751 CF-patients, aged 14 years and over. It comprised questions about access to healthcare, anxiety and depression, smoking, alcohol, drug and psychotropic drug consumption, adherence to CF treatment, and constraints. A semi-structured comprehensive interview was performed no later than 1 month after the end of the lockdown in 16 CF-patients. RESULTS: The mean age of the population was 28.0 [interquartile range (IQR) 20.0–37.0] years old. More than 75% of in-person consultations scheduled during the lockdown were canceled. Alternatively, 27% were postponed, and telehealth consultations were proposed and accepted in almost 40% of cases. More than 75% of the scheduled physiotherapy sessions were canceled and replaced mainly by self-drainage. Annual follow-up clinic visits were consistently postponed whereas required hospitalizations at CF centers for exacerbation were maintained in most cases. While 43.2% CF-patients had signs of anxiety, 51.0% presented symptoms of depression, both associated with increased use of psychotic medications and inversely correlated to COVID-19 prevalence. Among the lower and lower middle classes, very little medical information was obtained or requested by the patient, participation to sports or other activities was low, while excessive home confinement and isolation were more frequent. In contrast, in the upper middle and upper classes, individuals solicitated help to their CF centre, had more physical activities, and maintained contact with friends or families. CONCLUSION: The first lockdown in France had only minimal impact on the management care of CF-patients but was associated with increased symptoms of anxiety and depression, together with behavioral changes that varied with social class. TRIAL REGISTRATION: NCT04463628. Frontiers Media S.A. 2022-11-14 /pmc/articles/PMC9703073/ /pubmed/36452951 http://dx.doi.org/10.3389/fpubh.2022.978627 Text en Copyright © 2022 Oubaya, Pombet, Delestrain, Remus, Douvry, Grenet, Corvol, Thouvenin, Prulière-Escabasse, Mounir, Argoud, Fretigne, Costes, Mackiewicz, Jung, Ahamada, Lanone, Maitre, Bégot and Epaud. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Oubaya, Nadia
Pombet, Thibaud
Delestrain, Celine
Remus, Natascha
Douvry, Benoit
Grenet, Dominique
Corvol, Harriet
Thouvenin, Guillaume
Prulière-Escabasse, Virginie
Mounir, Hakima
Argoud, Dominique
Fretigne, Cédric
Costes, Laurence
Mackiewicz, Marie-Pierre
Jung, Camille
Ahamada, Laitissia
Lanone, Sophie
Maitre, Bernard
Bégot, Anne-Cécile
Epaud, Ralph
Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN)
title Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN)
title_full Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN)
title_fullStr Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN)
title_full_unstemmed Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN)
title_short Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN)
title_sort impact of the covid-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in france during 2020 (muconfin)
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703073/
https://www.ncbi.nlm.nih.gov/pubmed/36452951
http://dx.doi.org/10.3389/fpubh.2022.978627
work_keys_str_mv AT oubayanadia impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT pombetthibaud impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT delestrainceline impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT remusnatascha impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT douvrybenoit impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT grenetdominique impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT corvolharriet impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT thouveninguillaume impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT pruliereescabassevirginie impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT mounirhakima impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT argouddominique impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT fretignecedric impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT costeslaurence impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT mackiewiczmariepierre impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT jungcamille impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT ahamadalaitissia impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT lanonesophie impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT maitrebernard impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT begotannececile impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin
AT epaudralph impactofthecovid19pandemicandassociatedlockdownmeasuresonthemanagementhealthandbehaviorofthecysticfibrosispopulationinfranceduring2020muconfin